Haemonetics Corp
NYSE:HAE

Watchlist Manager
Haemonetics Corp Logo
Haemonetics Corp
NYSE:HAE
Watchlist
Price: 91.7 USD -0.09% Market Closed
Market Cap: 4.7B USD
Have any thoughts about
Haemonetics Corp?
Write Note

Haemonetics Corp
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Haemonetics Corp
Cash Equivalents Peer Comparison

Comparables:
XRAY
ICUI
ALGN
LNTH
MMSI

Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Haemonetics Corp
NYSE:HAE
Cash Equivalents
$299.3m
CAGR 3-Years
16%
CAGR 5-Years
22%
CAGR 10-Years
9%
DENTSPLY SIRONA Inc
NASDAQ:XRAY
Cash Equivalents
$296m
CAGR 3-Years
2%
CAGR 5-Years
6%
CAGR 10-Years
12%
ICU Medical Inc
NASDAQ:ICUI
Cash Equivalents
$302.6m
CAGR 3-Years
-13%
CAGR 5-Years
1%
CAGR 10-Years
3%
Align Technology Inc
NASDAQ:ALGN
Cash Equivalents
$1B
CAGR 3-Years
-6%
CAGR 5-Years
16%
CAGR 10-Years
19%
Lantheus Holdings Inc
NASDAQ:LNTH
Cash Equivalents
$866.4m
CAGR 3-Years
112%
CAGR 5-Years
62%
CAGR 10-Years
41%
Merit Medical Systems Inc
NASDAQ:MMSI
Cash Equivalents
$523.1m
CAGR 3-Years
97%
CAGR 5-Years
70%
CAGR 10-Years
55%

See Also

What is Haemonetics Corp's Cash Equivalents?
Cash Equivalents
299.3m USD

Based on the financial report for Sep 28, 2024, Haemonetics Corp's Cash Equivalents amounts to 299.3m USD.

What is Haemonetics Corp's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
9%

Over the last year, the Cash Equivalents growth was -15%. The average annual Cash Equivalents growth rates for Haemonetics Corp have been 16% over the past three years , 22% over the past five years , and 9% over the past ten years .

Back to Top